Psychotropic Drugs Market Size, Share, Growth Analysis Report 2032

What is the projected value for the Psychotropic Drugs Market during 2024 to 2032?

The global Psychotropic Drugs Market size was valued at USD 21.85 Billion in 2023 and is predicted to reach USD 37.87 Billion by the end of 2032. The market is expected to grow with a CAGR of 6.3% during the forecast period. The report analyzes the global Psychotropic Drugs Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Psychotropic Drugs industry.

Request Free Sample

Global Psychotropic Drugs Market: Overview

Psychotropic drugs are used to treat psychosis. They can be consumed either as a prescribed drug or misused drugs. These drugs belong to the different categories which are adopted in treating a wide range of conditions. These drugs function by modifying the level of neurotransmitters or brain chemicals.

There are 5 different types of psychotropic drugs available in the market namely, mood stabilizers, antidepressants, anti-anxiety agents, antipsychotics, and stimulants. Some of them need special monitoring because they pose serious side effects to the human body by facilitating drugs like cocaine. These psychotropic drugs are also called psychodynamic drugs. Some of the common disorders that required psychotic drugs include bipolar disorder, delusions, hallucinations, and others.

Global Psychotropic Drugs Market: Growth Factors

The growing prevalence of psychotic disorders and epilepsy will significantly steer the growth of the global psychotropic drugs market. However, the patent expiry of some of the prominent drugs is posing huge potential to the global psychotropic drugs market. The growing drug abuse and addiction to antipsychotic drugs and over-prescription of drugs are some of the key factors complementing the growth. Psychotropic drugs modify perception, thoughts, mood, and behavior.

According to the data in Our Work study, millions of people are living with mental health disorders. Therefore, it is concluded that a growing number of the population are suffering from psychological disorders, which in turn is expected to augment the growth of the market over the forecast period. Also, according to the World Health Organization, the geriatric population is expected to rise from 900 million in 2015 to a billion in 2050.

The huge population is at risk of mental disorders hence it is concluded that the growing geriatric population will pose huge demand for such drugs in the forthcoming years. Public health organizations and government bodies are launching several campaigns and programs to create awareness regarding mental health.

In addition, prominent market leaders are actively emphasizing research and development activities to launch innovative and advanced psychological drugs which can treat the disorders in a safe and effective manner. For instance, as per a study from the World Health Organization, about two-thirds of humans knowing they are suffering from mental disorders never seek assistance or treatment from healthcare professionals. Therefore, the awareness campaigns launched by authorities are likely to positively impact the growth of the global psychotropic drugs market. Also, several related studies and research are going on globally to learn ‘how to’ of these drugs, which in turn is likely to bring sustainable and substantial improvements in the growth rate of the market.

Key Insights

• As per the analysis shared by our research analyst, the global Psychotropic Drugs Market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2024-2032).
• In terms of revenue, the global Psychotropic Drugs Market size was valued at around USD 21.85 Billion in 2023 and is projected to reach USD 37.87 Billion by 2032.
• Based on the distribution channel, In the psychotropic drugs market, the hospital pharmacies segment is the most dominant distribution channel. This dominance is primarily driven by the high volume of prescriptions issued by healthcare professionals within hospital settings, especially for patients with acute mental health conditions. Hospitals often stock a wide range of psychotropic medications to cater to urgent psychiatric needs, offering both inpatient and outpatient services, which boosts their overall market share compared to retail pharmacies and online platforms.
• Based on the drug types, Among the various drug types, antipsychotics represent the most dominant segment in the psychotropic drugs market. Antipsychotics are widely prescribed for managing serious mental health disorders such as schizophrenia, bipolar disorder, and severe depression, which have a high global prevalence. Their effectiveness in stabilizing mood and reducing psychotic symptoms, combined with increasing awareness and diagnosis rates, continues to drive their leading position over other drug types like antidepressants, mood stabilizers, and anxiolytics.
• Based on the region, Geographically, North America is the most dominant region in the psychotropic drugs market. The region's strong position can be attributed to factors such as high mental health awareness, well-established healthcare infrastructure, higher healthcare spending, and greater acceptance of psychotropic medication use. Additionally, the presence of major pharmaceutical companies and favorable reimbursement policies in the United States and Canada further reinforce North America's leadership in this market.

Psychotropic Drugs Market: Report Scope

Global Psychotropic Drugs Market: Segmentation

Request Free Sample​

The global psychotropic drugs market can be segmented into the distribution channel, drug types, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

By drug type, the market can be segmented into stimulants, hypnotics, antiepileptic drugs (AEDs), anti-anxiety (AA), mood stabilizers (MS), serotonin-norepinephrine reuptake inhibitors (SNRIs), selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), antidepressants (AD), clozapine, risperidone, quetiapine, thioridazine, chlorpromazine, anti-psychotics (AP), anesthetics, and analgesics.

By distribution channel, the market can be segmented into drug store online pharmacies, retail pharmacies, and hospital pharmacies. Hospital pharmacies account for the largest share of the global psychotropic drugs market due to a wide number of patients' visits to hospitals for effective treatments for a wide range of diseases.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Global Psychotropic Drugs Market: Regional Analysis

Request Free Sample

North America accounts for the largest share of the global psychotropic drugs market due to the growing prevalence of mental disorders in the region. The fast-proliferating healthcare sector in the region is another key factor that will help the regional market to grow at a fast pace. Also, the growing awareness among people and their willingness to open up regarding their mental suffering is likely to further create several lucrative growth opportunities in the market in the forthcoming years.

Europe accounts for the second-largest share in the global psychotropic drugs market due to the presence of favorable reimbursement medical policies in the region along with the growing initiatives by the government to lower the burden of mental disorders in the region.

Asia Pacific is expected to be the fastest-growing region in the global psychotropic drugs market due to the transforming lifestyle of the people in the region. The high adoption of western culture along with rapidly growing urbanization is likely to fuel the mental stress on people, which in turn will also escalate the growing number of mental disorders in the forthcoming years.

Global Psychotropic Drugs Market: Competitive Players 

Some of the significant players in the global psychotropic drugs market are:

• Takeda Pharmaceutical Company Limited
• Acadia Pharmaceuticals Inc.
• Axsome Therapeutics, Inc.
• Novartis AG
• Mylan N.V.
• Pfizer Inc.
• Allergan
• Janssen Global Services, LLC
• Eli Lilly and Company
• and Alkermes

Global Psychotropic Drugs Market: Segmentation

By Type

• Analgesics
• Anesthetics

By Application

• Hospital Pharmacies
• Retail Pharmacies

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

• What Reports Provides
• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, ongoing, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.